MedPath

Effect of MSD on FCR Among Gastric Cancer Survivors

Not Applicable
Recruiting
Conditions
Stomach Cancer;Clinical Control Trial
Interventions
Behavioral: Marital self disclosure
Registration Number
NCT05606549
Lead Sponsor
University of Malaya
Brief Summary

The goal of this clinical trial is to explores the effect of marital self disclosure intervention on fear of cancer recurrence and dyadic coping ability in gastric cancer survivors and their spouses. The main questions are: What is the level of fear of cancer recurrence among gastric cancer survivors and their spouse? What is the level of dyadic coping ability among gastric cancer survivors and their spouse?What is the effect of marital self-disclosure intervention on fear of cancer recurrence and dyadic coping ability in the gastric cancer survivors and their spouses? Participants will accept the intervention of marital self disclosure for 4 times (4 cycles of chemotherapy) with different topics. Researchers will compare with control group to see if the level of fear of cancer recurrence and dyadic coping ability will be improved.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
84
Inclusion Criteria
  • The disease meets the diagnostic criteria of "Guidelines for Diagnosis and Treatment of Gastric Cancer"(Department of Medical Affairs, 2019), the preoperative gastroscopy and pathological diagnosis are advanced gastric cancer, and the postoperative pathological classification is type II, III or IV
  • Age ≥ 18 years
  • Able to write and oral communicate effectively by themself
  • The main caregiver is their spouse
  • Clear consciousness, no understanding barriers
  • Agree to participate in this study
Exclusion Criteria
  • History of receiving a structured psychological intervention from a psychiatrist or a psychologist
  • Cognitive disorders or psychiatric disorders (according to the DSM-V)
  • Severe visual, hearing and speech impairment
  • With previous or concurrent malignant tumors
  • With severe complications, such as gastrointestinal obstruction, perforation, etc.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
marital self disclosureMarital self disclosure-
Primary Outcome Measures
NameTimeMethod
Fear of Progression Questionnaire-Short form (FoP-Q-SF) for Partners4 months

FoP-Q-SF for Partners is developed by Zimmermann et al. (2011) based on the structure of the FoP-Q-SF scale to assess the degree of disease progression of the patient's spouse's fear of disease. FoP-Q-SF for Partners includes 12 items, adopting 5-point Likert scale, 1 point representing "never" and 5 points representing "always", with a total score ranging from 12 to 60, with higher scores indicating higher fear of their spouse's disease progression.

Fear of Progression Questionnaire-Short form (FoP-Q-SF) for Patients4 months

The FoP-Q-SF is a one-dimensional scale constructed by on the basis of the Fear of Progression Questionnaire (FoP-Q). The FoP-Q-SF for Patients scale includes 12 items, using 5-point Likert Scale, 1 point means "never", 5 points means "always", with a total score ranging from 12 to 60, with higher scores indicating higher fear of disease progression.

Secondary Outcome Measures
NameTimeMethod
Dyadic Coping Inventory(DCI)4 months

DCI based on the system interaction model was originally developed by Bodenmann ( 2000), which includes 6 dimensions, 55 items, and use Likert 5-point scale. After further improvement, the DCI (Bodenmann \& Randall, 2012) was revised to 37 items and measured on a 5-point Likert scale, ranging from 1 (not at all/very rarely) to 5 (very often).

Trial Locations

Locations (1)

Jingjiang people's Hospital

🇨🇳

Taizhou, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath